PulseAugur
LIVE 07:18:38
research · [1 source] · · 中文(ZH) AI医疗迎来高速发展窗口期,8只个股一季报净利润增幅超100%
0
research

AI healthcare sees rapid growth, with 8 companies reporting over 100% profit increase

The AI healthcare sector is experiencing a period of rapid growth, driven by supportive policies, increased capital investment, and accelerated expansion by major tech companies. Out of 103 listed companies in China involved in AI healthcare, 29 reported year-over-year increases in net profit for the first quarter, with eight of them showing growth exceeding 100%. This surge has led to a rise in related concept stocks, with some, like Berry Genomics and DaAn Gene, reaching their daily limit. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

IMPACT Indicates strong growth potential and investment opportunities in the AI healthcare sector, driven by policy and corporate investment.

RANK_REASON The article discusses significant financial performance and market trends within the AI healthcare sector, including specific company earnings and stock performance. [lever_c_demoted from significant: ic=1 ai=0.4]

Read on 36氪 (36Kr) →

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    AI healthcare enters a period of rapid development, with 8 stocks seeing net profit growth exceeding 100% in the first quarter.

    在政策持续赋能、资本加码入局、互联网大厂加速布局的多重利好加持下,AI医疗产业迎来高速发展窗口期。据数据宝统计,A股中布局AI医疗产业链的上市公司共有103家,包括医药生物、计算机行业上市公司。5月8日早盘,概念股涨多跌少,平均上涨0.74%,贝瑞基因、达安基因涨停。从业绩来看,29只AI医疗概念股一季报归母净利润实现同比增长,其中一品红、昭衍新药、博济医药等8只个股增幅在100%以上。(证券时报)